Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Completed

Plain-English translation of NCT04115293 on ClinicalTrials.gov ↗ · Source last updated July 2025 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(77 sites)

United States

Site 41: Diagnostic and Medical Clinic, Mobile, Alabama

Site 116: Neuromuscular Clinic and Research Center, Phoenix, Arizona

Site 4: University of Southern California, Los Angeles, California

Site 31: University of California Irvine, Orange, California

Site 220: Investigator Site, Pasadena, California